Indication

Adjunct therapy for peptic ulcer disease

Adjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract. Read more about Adjunct therapy for peptic ulcer disease

57 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Adjunct therapy for peptic ulcer disease therapies.

Showing 19–27 of 57 drugs

GLYCOPYRROLATE

GLYCOPYRROLATE·VAGAL REFLEX BRADYCARDIA·+2
FRESENIUS KABI

GLYCOPYRROLATE

GLYCOPYRROLATE·VAGAL REFLEX BRADYCARDIA·+2
FRESENIUS KABI

GLYCOPYRROLATE

GLYCOPYRROLATE·VAGAL REFLEX BRADYCARDIA·+2
Hikma Pharmaceuticals USA

GLYCOPYRROLATE

GLYCOPYRROLATE·VAGAL REFLEX BRADYCARDIA·+2
NORTHSTAR RX LL

GLYCOPYRROLATE

GLYCOPYRROLATE·VAGAL REFLEX BRADYCARDIA·+2
PIRAMAL CRITICA
Filter & compare in the drug finder →Opens the drug finder with Adjunct therapy for peptic ulcer disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Adjunct therapy for peptic ulcer disease.

Adjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract.

This condition affects the stomach and proximal duodenum, typically presenting clinically with burning epigastric pain, dyspepsia, fullness, and potential complications such as hemorrhage, perforation, or obstruction.

Pathophysiologically, it is characterized by mucosal barrier disruption that penetrates the muscularis mucosae, driven by an imbalance between aggressive luminal factors—principally gastric acid and pepsin—and protective defense mechanisms, most frequently precipitated by *Helicobacter pylori* infection or the use of nonsteroidal anti-inflammatory drugs.

In this clinical setting, adjunctive agents serve as complementary measures to alleviate persistent symptoms, enhance mucosal defense, or reduce gastric secretions when primary curative strategies require augmentation.

Personalize your experience

Follow Adjunct therapy for peptic ulcer disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it